Literature DB >> 19299454

Up-regulation of cyclooxygenase-2 expression and prostaglandin E2 production in human endometriotic cells by macrophage migration inhibitory factor: involvement of novel kinase signaling pathways.

Cédric Carli1, Christine N Metz, Yousef Al-Abed, Paul H Naccache, Ali Akoum.   

Abstract

Cyclooxygenase (COX) is the rate-limiting enzyme in the metabolic conversion of arachidonic acid to prostaglandins (PGs), including prostaglandin E(2) (PGE(2)), a major mediator of inflammation and angiogenesis. Herein, we report that macrophage migration inhibitory factor (MIF), a potent proinflammatory and growth-promoting factor found at elevated concentrations in the peritoneal fluid of women with endometriosis and active endometriosis lesions, acts directly on ectopic endometrial cells to stimulate the synthesis of COX-2, the inducible form of COX, and the release of PGE(2). MIF treatment strongly activated p38 and ERK MAPK, and specific inhibitors of both pathways completely blocked basal and MIF-induced PGE(2) synthesis. Whereas p38 inhibitors negatively affected the stimulated synthesis of COX-2 and that of PGE(2), ERK inhibitors only decreased the production of PGE(2). These findings show for the first time a direct role for MIF in the up-regulation of COX-2 synthesis and PGE(2) secretion in ectopic endometrial cells. They further indicate that whereas p38 and ERK MAPK signaling pathways both play a significant role in the regulation of basal and MIF-induced synthesis of PGE(2) by ectopic endometrial cells, only p38 kinase is involved in the regulation of COX-2 expression in these cells. This suggests that MIF acts at more than one level to stimulate the synthesis of PGE(2) and triggers the coordinate activation of multiple enzymes in the biosynthesis pathway. Our data provide evidence for a novel mechanism by which MIF can induce a proinflammatory phenotype in ectopic endometrial cells, and favor the establishment of endometriosis and its related clinical symptoms.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19299454      PMCID: PMC2703510          DOI: 10.1210/en.2008-1088

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  72 in total

Review 1.  Immunological factors and their role in the genesis and development of endometriosis.

Authors:  Charalambos Siristatidis; Christos Nissotakis; Charalambos Chrelias; Helen Iacovidou; Emmanuel Salamalekis
Journal:  J Obstet Gynaecol Res       Date:  2006-04       Impact factor: 1.730

Review 2.  Macrophage-migration inhibitory factor: role in inflammatory diseases and graft rejection.

Authors:  A Javeed; Y Zhao; Y Zhao
Journal:  Inflamm Res       Date:  2008-02       Impact factor: 4.575

Review 3.  Prostaglandin E synthase: a novel drug target for inflammation and cancer.

Authors:  Makoto Murakami; Ichiro Kudo
Journal:  Curr Pharm Des       Date:  2006       Impact factor: 3.116

4.  Postgestational effects of macrophage migration inhibitory factor on embryonic implantation in mice.

Authors:  Patrick Kibangou Bondza; Christine N Metz; Ali Akoum
Journal:  Fertil Steril       Date:  2007-11-26       Impact factor: 7.329

Review 5.  Mechanisms of disease: macrophage migration inhibitory factor in SLE, RA and atherosclerosis.

Authors:  Sally Ayoub; Michael J Hickey; Eric F Morand
Journal:  Nat Clin Pract Rheumatol       Date:  2008-02

6.  Microparticles stimulate the synthesis of prostaglandin E(2) via induction of cyclooxygenase 2 and microsomal prostaglandin E synthase 1.

Authors:  Astrid Jüngel; Oliver Distler; Ursula Schulze-Horsel; Lars C Huber; Huy Riem Ha; Beat Simmen; Joachim R Kalden; David S Pisetsky; Steffen Gay; Jörg H W Distler
Journal:  Arthritis Rheum       Date:  2007-11

Review 7.  Endometriosis and angiogenesis.

Authors:  K May; C M Becker
Journal:  Minerva Ginecol       Date:  2008-06

Review 8.  Antiangiogenic and vascular-disrupting agents in endometriosis: pitfalls and promises.

Authors:  Anne Van Langendonckt; Jacques Donnez; Sylvie Defrère; Gerard A J Dunselman; Patrick G Groothuis
Journal:  Mol Hum Reprod       Date:  2008-04-22       Impact factor: 4.025

9.  Prostaglandin E2 regulates angiogenesis via activation of fibroblast growth factor receptor-1.

Authors:  Federica Finetti; Raffaella Solito; Lucia Morbidelli; Antonio Giachetti; Marina Ziche; Sandra Donnini
Journal:  J Biol Chem       Date:  2007-11-26       Impact factor: 5.157

10.  Extracellularly signal-regulated kinase activity in the human endometrium: possible roles in the pathogenesis of endometriosis.

Authors:  William Murk; Cem S Atabekoglu; Hakan Cakmak; Aylin Heper; Arzu Ensari; Umit A Kayisli; Aydin Arici
Journal:  J Clin Endocrinol Metab       Date:  2008-06-17       Impact factor: 5.958

View more
  30 in total

1.  The MIF homologue D-dopachrome tautomerase promotes COX-2 expression through β-catenin-dependent and -independent mechanisms.

Authors:  Dan Xin; Beatriz E Rendon; Ming Zhao; Millicent Winner; Arlixer McGhee Coleman; Robert A Mitchell
Journal:  Mol Cancer Res       Date:  2010-11-11       Impact factor: 5.852

2.  The expression of microRNA-451 in human endometriotic lesions is inversely related to that of macrophage migration inhibitory factor (MIF) and regulates MIF expression and modulation of epithelial cell survival.

Authors:  Amanda Graham; Tommaso Falcone; Warren B Nothnick
Journal:  Hum Reprod       Date:  2015-01-29       Impact factor: 6.918

3.  CD74 and macrophage migration inhibitory factor as therapeutic targets in gastric cancer.

Authors:  Ying-Xia Zheng; Ming Yang; Ting-Ting Rong; Xiang-Liang Yuan; Yan-Hui Ma; Zhi-Hao Wang; Li-Song Shen; Long Cui
Journal:  World J Gastroenterol       Date:  2012-05-14       Impact factor: 5.742

4.  Inhibition of macrophage migration inhibitory factor reduces endometriotic implant size in mice with experimentally induced disease.

Authors:  Warren B Nothnick; Arlene Colvin; Kai Fan Cheng; Yousef Al-Abed
Journal:  J Endometr       Date:  2011-09-30

Review 5.  Endometriosis and ovarian cancer: a review of clinical, pathologic, and molecular aspects.

Authors:  Jian-Jun Wei; Josette William; Serdar Bulun
Journal:  Int J Gynecol Pathol       Date:  2011-11       Impact factor: 2.762

6.  Suppression of COUP-TFII by proinflammatory cytokines contributes to the pathogenesis of endometriosis.

Authors:  Shih-Chieh Lin; Yo-Hua Li; Meng-Hsing Wu; Yu-Fan Chang; Dong-Kee Lee; Sophia Y Tsai; Ming-Jer Tsai; Shaw-Jenq Tsai
Journal:  J Clin Endocrinol Metab       Date:  2014-01-01       Impact factor: 5.958

Review 7.  Role of inflammation in benign gynecologic disorders: from pathogenesis to novel therapies†.

Authors:  Abdelrahman AlAshqar; Lauren Reschke; Gregory W Kirschen; Mostafa A Borahay
Journal:  Biol Reprod       Date:  2021-07-02       Impact factor: 4.285

8.  Intervillous macrophage migration inhibitory factor is associated with adverse birth outcomes in a study population in Central India.

Authors:  Puspendra P Singh; Naomi W Lucchi; Anna Blackstock; Venkatachalam Udhayakumar; Neeru Singh
Journal:  PLoS One       Date:  2012-12-13       Impact factor: 3.240

9.  D-dopachrome tautomerase activates COX2/PGE2 pathway of astrocytes to mediate inflammation following spinal cord injury.

Authors:  Huiyuan Ji; Yuxin Zhang; Chen Chen; Hui Li; Bingqiang He; Ting Yang; Chunshuai Sun; Huifei Hao; Xingyuan Zhang; Yingjie Wang; Yue Zhou; Zhenjie Zhu; Yuming Hu; Aihong Li; Aisong Guo; Yongjun Wang
Journal:  J Neuroinflammation       Date:  2021-06-11       Impact factor: 8.322

10.  Interplay between Misplaced Müllerian-Derived Stem Cells and Peritoneal Immune Dysregulation in the Pathogenesis of Endometriosis.

Authors:  Antonio Simone Laganà; Emanuele Sturlese; Giovanni Retto; Vincenza Sofo; Onofrio Triolo
Journal:  Obstet Gynecol Int       Date:  2013-06-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.